Analysis depression: Difference between revisions

(9 intermediate revisions by 3 users not shown)

Line 1:

<onlyinclude>'''Analysis ~~suppression~~''' ~~can be described~~ as a distinct decrease in ~~one~~'s overall ability to process information and logically or creatively analyze concepts, ideas, and scenarios. The experience of this effect leads to significant difficulty contemplating or understanding basic ideas in a manner which can temporarily prevent normal cognitive functioning.

<onlyinclude>'''Analysis depression''' is defined as a distinct decrease in a person's overall ability to process information<ref name="KnowlesDavid2010">{{cite journal|last1=Knowles|first1=Emma E.M.|last2=David|first2=Anthony S.|last3=Reichenberg|first3=Abraham|title=Processing Speed Deficits in Schizophrenia: Reexamining the Evidence|journal=American Journal of Psychiatry|volume=167|issue=7|year=2010|pages=828–835|issn=0002-953X|doi=10.1176/appi.ajp.2010.09070937}}</ref><ref name="TakeuchiSuzuki2013">{{cite journal|last1=Takeuchi|first1=H.|last2=Suzuki|first2=T.|last3=Remington|first3=G.|last4=Bies|first4=R. R.|last5=Abe|first5=T.|last6=Graff-Guerrero|first6=A.|last7=Watanabe|first7=K.|last8=Mimura|first8=M.|last9=Uchida|first9=H.|title=Effects of Risperidone and Olanzapine Dose Reduction on Cognitive Function in Stable Patients With Schizophrenia: An Open-Label, Randomized, Controlled, Pilot Study|journal=Schizophrenia Bulletin|volume=39|issue=5|year=2013|pages=993–998|issn=0586-7614|doi=10.1093/schbul/sbt090}}</ref><ref name="FriedWatkinson2005">{{cite journal|last1=Fried|first1=P|last2=Watkinson|first2=B|last3=Gray|first3=R|title=Neurocognitive consequences of marihuana—a comparison with pre-drug performance|journal=Neurotoxicology and Teratology|volume=27|issue=2|year=2005|pages=231–239|issn=08920362|doi=10.1016/j.ntt.2004.11.003}}</ref> and logically or creatively analyze concepts, ideas, and scenarios.<ref name="KawaiYamakawa2006">{{cite journal|last1=Kawai|first1=Nobutoshi|last2=Yamakawa|first2=Yuriko|last3=Baba|first3=Atsuomi|last4=Nemoto|first4=Kiyotaka|last5=Tachikawa|first5=Hirokazu|last6=Hori|first6=Takafumi|last7=Asada|first7=Takashi|last8=Iidaka|first8=Tetsuya|title=High-dose of multiple antipsychotics and cognitive function in schizophrenia: The effect of dose-reduction|journal=Progress in Neuro-Psychopharmacology and Biological Psychiatry|volume=30|issue=6|year=2006|pages=1009–1014|issn=02785846|doi=10.1016/j.pnpbp.2006.03.013}}</ref> The experience of this effect leads to significant difficulty contemplating or understanding basic ideas in a manner which can temporarily prevent normal cognitive functioning.

Analysis suppression is often accompanied by other coinciding effects such as [[sedation]], [[thought deceleration]], and [[emotion suppression]]. It is most commonly induced under the influence of [[dosage#~~common~~|~~moderate~~]] [[dosage|dosages]] of [[antipsychotic]] compounds, such as [[quetiapine]], [[haloperidol]], and [[risperidone]]. However, it can also occur in a less consistent form under the influence of [[dosage#heavy|heavy]] dosages of [[dissociative|dissociatives]], [[cannabinoid|cannabinoids]], and [[GABAergic|GABAergic]] [[depressant|depressants]].

Analysis suppression is often accompanied by other coinciding effects such as [[sedation]], [[thought deceleration]], and [[emotion suppression]]. It is most commonly induced under the influence of [[dosage#heavy|heavy]] [[dosage|dosages]] of [[antipsychotic]] compounds,<ref name="KnowlesDavid2010" /><ref name="TakeuchiSuzuki2013" /><ref name="KawaiYamakawa2006" /> and is associated with long term use of such drugs<ref name="HusaMoilanen2017">{{cite journal|last1=Husa|first1=Anja P.|last2=Moilanen|first2=Jani|last3=Murray|first3=Graham K.|last4=Marttila|first4=Riikka|last5=Haapea|first5=Marianne|last6=Rannikko|first6=Irina|last7=Barnett|first7=Jennifer H.|last8=Jones|first8=Peter B.|last9=Isohanni|first9=Matti|last10=Remes|first10=Anne M.|last11=Koponen|first11=Hannu|last12=Miettunen|first12=Jouko|last13=Jääskeläinen|first13=Erika|title=Lifetime antipsychotic medication and cognitive performance in schizophrenia at age 43 years in a general population birth cohort|journal=Psychiatry Research|volume=247|year=2017|pages=130–138|issn=01651781|doi=10.1016/j.psychres.2016.10.085}}</ref> like [[quetiapine]], [[haloperidol]], and [[risperidone]]. However, it can also occur in a less consistent form under the influence of [[dosage#heavy|heavy]] dosages of [[dissociative|dissociatives]], [[cannabinoid|cannabinoids]],<ref name="FriedWatkinson2005" /> and [[GABAergic|GABAergic]] [[depressant|depressants]]<ref name="ParaherakisCharney2009">{{cite journal|last1=Paraherakis|first1=Antonios|last2=Charney|first2=Dara A.|last3=Gill|first3=Kathryn|title=NEUROPSYCHOLOGICAL FUNCTIONING IN SUBSTANCE-DEPENDENT PATIENTS|journal=Substance Use & Misuse|volume=36|issue=3|year=2009|pages=257–271|issn=1082-6084|doi=10.1081/JA-100102625}}</ref>.

</onlyinclude>

===Psychoactive substances===

Compounds within our [[psychoactive substance index]] which may cause this effect include:

{{#ask:[[Category:Psychoactive substance]][[Effect::Analysis suppression]]|format=ul|Columns=2}}

===Experience reports===

Annectdotal reports which describe this effect with our [[experience index]] include:

{{#ask:[[Category:Experience]][[Effect::Analysis suppression]]|format=ul|Columns=2}}

===See also===

*[[Responsible use]]

Line 14:

Line 17:

===External links===

* [https://en.wikipedia.org/wiki/Psychoanalysis Psychoanalysis (Wikipedia)]

[[Category:Cognitive]] [[Category:~~suppression~~]] [[Category:Effect]]

===References===

[[Category:Cognitive]]

[[Category:Depression]]

[[Category:Effect]]

@@ Line 1: / Line 1: @@
-<onlyinclude>'''Analysis suppression''' can be described as a distinct decrease in one's overall ability to process information and logically or creatively analyze concepts, ideas, and scenarios. The experience of this effect leads to significant difficulty contemplating or understanding basic ideas in a manner which can temporarily prevent normal cognitive functioning.
+<onlyinclude>'''Analysis depression''' is defined as a distinct decrease in a person's overall ability to process information<ref name="KnowlesDavid2010">{{cite journal|last1=Knowles|first1=Emma E.M.|last2=David|first2=Anthony S.|last3=Reichenberg|first3=Abraham|title=Processing Speed Deficits in Schizophrenia: Reexamining the Evidence|journal=American Journal of Psychiatry|volume=167|issue=7|year=2010|pages=828–835|issn=0002-953X|doi=10.1176/appi.ajp.2010.09070937}}</ref><ref name="TakeuchiSuzuki2013">{{cite journal|last1=Takeuchi|first1=H.|last2=Suzuki|first2=T.|last3=Remington|first3=G.|last4=Bies|first4=R. R.|last5=Abe|first5=T.|last6=Graff-Guerrero|first6=A.|last7=Watanabe|first7=K.|last8=Mimura|first8=M.|last9=Uchida|first9=H.|title=Effects of Risperidone and Olanzapine Dose Reduction on Cognitive Function in Stable Patients With Schizophrenia: An Open-Label, Randomized, Controlled, Pilot Study|journal=Schizophrenia Bulletin|volume=39|issue=5|year=2013|pages=993–998|issn=0586-7614|doi=10.1093/schbul/sbt090}}</ref><ref name="FriedWatkinson2005">{{cite journal|last1=Fried|first1=P|last2=Watkinson|first2=B|last3=Gray|first3=R|title=Neurocognitive consequences of marihuana—a comparison with pre-drug performance|journal=Neurotoxicology and Teratology|volume=27|issue=2|year=2005|pages=231–239|issn=08920362|doi=10.1016/j.ntt.2004.11.003}}</ref> and logically or creatively analyze concepts, ideas, and scenarios.<ref name="KawaiYamakawa2006">{{cite journal|last1=Kawai|first1=Nobutoshi|last2=Yamakawa|first2=Yuriko|last3=Baba|first3=Atsuomi|last4=Nemoto|first4=Kiyotaka|last5=Tachikawa|first5=Hirokazu|last6=Hori|first6=Takafumi|last7=Asada|first7=Takashi|last8=Iidaka|first8=Tetsuya|title=High-dose of multiple antipsychotics and cognitive function in schizophrenia: The effect of dose-reduction|journal=Progress in Neuro-Psychopharmacology and Biological Psychiatry|volume=30|issue=6|year=2006|pages=1009–1014|issn=02785846|doi=10.1016/j.pnpbp.2006.03.013}}</ref> The experience of this effect leads to significant difficulty contemplating or understanding basic ideas in a manner which can temporarily prevent normal cognitive functioning.
-Analysis suppression is often accompanied by other coinciding effects such as [[sedation]], [[thought deceleration]], and [[emotion suppression]]. It is most commonly induced under the influence of [[dosage#common|moderate]] [[dosage|dosages]] of [[antipsychotic]] compounds, such as [[quetiapine]], [[haloperidol]], and [[risperidone]]. However, it can also occur in a less consistent form under the influence of [[dosage#heavy|heavy]] dosages of [[dissociative|dissociatives]], [[cannabinoid|cannabinoids]], and [[GABAergic|GABAergic]] [[depressant|depressants]].
+Analysis suppression is often accompanied by other coinciding effects such as [[sedation]], [[thought deceleration]], and [[emotion suppression]]. It is most commonly induced under the influence of [[dosage#heavy|heavy]] [[dosage|dosages]] of [[antipsychotic]] compounds,<ref name="KnowlesDavid2010" /><ref name="TakeuchiSuzuki2013" /><ref name="KawaiYamakawa2006" /> and is associated with long term use of such drugs<ref name="HusaMoilanen2017">{{cite journal|last1=Husa|first1=Anja P.|last2=Moilanen|first2=Jani|last3=Murray|first3=Graham K.|last4=Marttila|first4=Riikka|last5=Haapea|first5=Marianne|last6=Rannikko|first6=Irina|last7=Barnett|first7=Jennifer H.|last8=Jones|first8=Peter B.|last9=Isohanni|first9=Matti|last10=Remes|first10=Anne M.|last11=Koponen|first11=Hannu|last12=Miettunen|first12=Jouko|last13=Jääskeläinen|first13=Erika|title=Lifetime antipsychotic medication and cognitive performance in schizophrenia at age 43 years in a general population birth cohort|journal=Psychiatry Research|volume=247|year=2017|pages=130–138|issn=01651781|doi=10.1016/j.psychres.2016.10.085}}</ref> like [[quetiapine]], [[haloperidol]], and [[risperidone]]. However, it can also occur in a less consistent form under the influence of [[dosage#heavy|heavy]] dosages of [[dissociative|dissociatives]], [[cannabinoid|cannabinoids]],<ref name="FriedWatkinson2005" /> and [[GABAergic|GABAergic]] [[depressant|depressants]]<ref name="ParaherakisCharney2009">{{cite journal|last1=Paraherakis|first1=Antonios|last2=Charney|first2=Dara A.|last3=Gill|first3=Kathryn|title=NEUROPSYCHOLOGICAL FUNCTIONING IN SUBSTANCE-DEPENDENT PATIENTS|journal=Substance Use & Misuse|volume=36|issue=3|year=2009|pages=257–271|issn=1082-6084|doi=10.1081/JA-100102625}}</ref>.
 </onlyinclude>
 ===Psychoactive substances===
 Compounds within our [[psychoactive substance index]] which may cause this effect include:
 {{#ask:[[Category:Psychoactive substance]][[Effect::Analysis suppression]]|format=ul|Columns=2}}
+===Experience reports===
+Annectdotal reports which describe this effect with our [[experience index]] include:
+{{#ask:[[Category:Experience]][[Effect::Analysis suppression]]|format=ul|Columns=2}}
 ===See also===
 *[[Responsible use]]
@@ Line 14: / Line 17: @@
 ===External links===
 * [https://en.wikipedia.org/wiki/Psychoanalysis Psychoanalysis (Wikipedia)]
-[[Category:Cognitive]] [[Category:suppression]] [[Category:Effect]]
+===References===
+<references />
+[[Category:Cognitive]]
+[[Category:Depression]]
+[[Category:Effect]]